{"description":"Adverse events were collected at each visit using a adverse event questionnaire as well as assessment by a study-physician.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":15,"description":"15 subjects were treated with combined 60mg denosumab every six months, 30 mg cinacalcet daily and 50 micrograms vitamin-D3 daily.","id":"EG000","otherNumAffected":13,"otherNumAtRisk":15,"seriousNumAffected":2,"seriousNumAtRisk":15,"title":"Combined Treatment."},{"deathsNumAffected":0,"deathsNumAtRisk":16,"description":"16 subjects received 60 mg denosumab every six months, placebo and 50 micrograms vitamin-D daily.","id":"EG001","otherNumAffected":15,"otherNumAtRisk":16,"seriousNumAffected":1,"seriousNumAtRisk":16,"title":"Denosumab Monotherapy"},{"deathsNumAffected":0,"deathsNumAtRisk":15,"description":"15 subjects will receive a saline injection every six months(blinded), placebo-tablets and 50 micrograms vitamin-D daily.","id":"EG002","otherNumAffected":15,"otherNumAtRisk":15,"seriousNumAffected":3,"seriousNumAtRisk":15,"title":"Placebo"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":16,"numEvents":7},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Leg edema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1},{"groupId":"EG001","numAffected":4,"numAtRisk":16,"numEvents":9},{"groupId":"EG002","numAffected":2,"numAtRisk":15,"numEvents":2}],"term":"Coughing"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":16,"numEvents":6},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":15,"numEvents":36},{"groupId":"EG001","numAffected":3,"numAtRisk":16,"numEvents":15},{"groupId":"EG002","numAffected":4,"numAtRisk":15,"numEvents":20}],"term":"Paraesthesia, hands"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":15,"numEvents":17},{"groupId":"EG001","numAffected":3,"numAtRisk":16,"numEvents":27},{"groupId":"EG002","numAffected":2,"numAtRisk":15,"numEvents":23}],"term":"Paraesthesia, feet"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":4},{"groupId":"EG001","numAffected":1,"numAtRisk":16,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":16,"numEvents":2},{"groupId":"EG002","numAffected":2,"numAtRisk":15,"numEvents":5}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":3},{"groupId":"EG001","numAffected":4,"numAtRisk":16,"numEvents":7},{"groupId":"EG002","numAffected":3,"numAtRisk":15,"numEvents":17}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":15,"numEvents":18},{"groupId":"EG001","numAffected":9,"numAtRisk":16,"numEvents":21},{"groupId":"EG002","numAffected":4,"numAtRisk":15,"numEvents":5}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":6},{"groupId":"EG001","numAffected":2,"numAtRisk":16,"numEvents":6},{"groupId":"EG002","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":15,"numEvents":2}],"term":"Gastroenteritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":16,"numEvents":5},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Cystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":15,"numEvents":14},{"groupId":"EG001","numAffected":6,"numAtRisk":16,"numEvents":17},{"groupId":"EG002","numAffected":3,"numAtRisk":15,"numEvents":20}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":12},{"groupId":"EG001","numAffected":1,"numAtRisk":16,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":15,"numEvents":33},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":15,"numEvents":12},{"groupId":"EG001","numAffected":6,"numAtRisk":16,"numEvents":20},{"groupId":"EG002","numAffected":4,"numAtRisk":15,"numEvents":5}],"term":"Upper respiratory tract infection"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Angina, Unstable"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Polycythaemia Vera"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":16,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Epilepsy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":15,"numEvents":0}],"term":"Inflammatory Bowel Disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Gastritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":16,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Erysipelas"}],"timeFrame":"Adverse events were collected for each participant from baseline until two weeks after treatment-cessation, up to 1 year."}